Probiotics for the gut – a summary of the evidence in irritable bowel syndrome


Event details


Webinar recording expired as at 31 Dec 2019 at 4pm (Syd/Melb time AUSTRALIA).
31 Dec 2019 at 1am (USA NY time) / 30 Dec at 10pm (USA CA time).



CLICK HERE TO SIGN UP TO YAKULT KNOWLEDGE for additional educational resources


Research is continually developing surrounding the application of probiotics and their role in health and disease. In this webinar, Dr Heidi Staudacher explores the evidence surrounding the use of probiotics, with special attention to her area of expertise- irritable bowel syndrome.


About the presenter:

Dr Heidi Staudacher is an Accredited Practising Dietitian with extensive experience in the clinical management of individuals with gastrointestinal disorders. She undertook her PhD at King’s College London investigating the role of diet in irritable bowel syndrome (IBS) and its impact on the gut microbiota. She has published numerous papers, including the first placebo-controlled trial of low FODMAP dietary advice in IBS. These have helped to progress our understanding of the potential efficacy of diet to manage gut symptoms, but also the consequences of altering diet on the gut microbiota and dietary quality. She recently joined the Food and Mood Centre in 2019 as an Alfred Deakin Postdoctoral Research fellow and will be extending her research to investigate the relationship between diet, the gut and mental health.


Supported by



Additional resources:
With regard to the question about the role of probiotics when taking antibiotics:
A: There is evidence in specific populations that probiotics may facilitate the restoration of the microbiota following antibiotic therapy but other studies have failed to show this. The general guidance from ISAPP is ‘consuming a probiotic may help with side effects such as diarrhea and help stabilize your gut microbiota’. Click here to access a recent general probiotic review that covered mechanisms and translating the science of probiotics into practice.

CPD/CEU hours are applicable for Australia, New Zealand, USA dietitians. Check your local country requirements to see if you can claim for continuing education.


CE certificate can be downloaded after completing the feedback survey

CDR Activity Number Live: 152295 / Recorded:152296 (recording CEU approved until 28 Nov 2022)
Activity Type: 171 Live Webinar OR 175 Recorded Pre-Approved CPE
CPE Level: 2

Suggested performance indicators:

10.4.2 Applies knowledge of pharmacotherapy and its effect on nutrient absorption, utilization and metabolism when developing and/or revising the plan of care.
8.1.5 Applies medical nutrition therapy in disease prevention and management.
8.3.1 Maintains the knowledge and skill to manage a variety of disease states and clinical conditions.
8.3.6 Keeps abreast of current nutrition and dietetics knowledge and trends.

Suggested learning need codes:

5220: Gastrointestinal disorders
5000: Medical Nutrition Therapy
3070: Pharmacological, drug/nutrient, herbal interaction

Presented By
Dr Heidi Staudacher
Professional Development
Duration1 hour
CPEUs Awarded1
Performance Indicators10.4.2, 8.1.5, 8.3.1, 8.3.6